Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-26, Stock:ABT, The news for the past five days is as follows:
2018-10-19: NEWS1: Thermo Fisher: Analysts’ Estimates and Recommendations.NEWS2: Gauging Analysts’ Views for NovoCure Stock.NEWS3: Analysts Expect IEHS Will Reach $32.NEWS4: Analysts Expect IEHS Will Reach $32.NEWS5: NovoCure’s Operational Performance in Q3 2018: What to Expect.NEWS6: Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant.NEWS7: 56% of Analysts Give ZBH a ‘Buy’ Rating before Its Q3 Earnings.NEWS8: AbbVie CFO William Chase Plans To Retire In Mid-2019.NEWS9: AbbVie CFO William Chase Plans To Retire In Mid-2019.
2018-10-22: NEWS1: Noteworthy ETF Inflows: IHI, MDT, ABT, TMO.NEWS2: Noteworthy ETF Inflows: IHI, MDT, ABT, TMO.
2018-10-23: NEWS1: Stocks to Buy, Stocks to Dump in This Volatile Market.
2018-10-24: NEWS1: Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings.NEWS2: Earnings Projections for Abbott Laboratories in 2018.NEWS3: Revenue Projections for Abbott Laboratories in 2018.NEWS4: A Performance Overview of Johnson & Johnson.NEWS5: These 10 companies are helping employees pay off their student loans.NEWS6: Abbott Laboratories: Why Analysts Are So Bullish.
2018-10-25: NEWS1: Abbott (ABT) Gains But Lags Market: What You Should Know.NEWS2: Merck & Co. Grows 5% in the Third Quarter.NEWS3: Abbott Laboratories’ Diagnostics Segment: 2018 Growth Forecasts.NEWS4: Abbott Laboratories’ Nutrition Business: A Turnaround Story.NEWS5: Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results.NEWS6: See what the IHS Markit Score report has to say about Abbott Laboratories..NEWS7: International Markets: Abbott Laboratories’ Key Revenue Driver.

Answer: Decrease